A primary benefit of the FDA Fast Track designation is how it accelerates the drug approval process. Early and continuous ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

Michael Mager of Precision Neuroscience, a brain implant startup rival to Elon Musk's Neuralink, sounds off on the future of ...

The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...

Investors are responding to Tesla CEO Elon Musk's close association with President-elect Donald Trump, anticipating a ...

Tom Oxley, the Australian-born chief executive of brain chip company Synchron, has praised ­Donald Trump for having a ...

Elon Musk’s backing of Donald Trump’s decisive victory for a second presidency gives the billionaire entrepreneur ...

Elon Musk's support for Trump could lead to significant policy shifts benefiting his companies. His potential role in the new ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

Musk has long criticized the FDA’s approval processes, which he believes hinder innovation at Neuralink. A sympathetic ...

Tesla shares were up 15% on November 6 after Trump’s election to a second term. At his brain-implant startup Neuralink, Musk ...